BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9885826)

  • 1. [Parkinson disease: monogenic forms and genetic susceptibility factors].
    Brice A
    Pathol Biol (Paris); 1998 Nov; 46(9):710-2. PubMed ID: 9885826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A susceptibility locus for Parkinson's disease maps to chromosome 2p13.
    Gasser T; Müller-Myhsok B; Wszolek ZK; Oehlmann R; Calne DB; Bonifati V; Bereznai B; Fabrizio E; Vieregge P; Horstmann RD
    Nat Genet; 1998 Mar; 18(3):262-5. PubMed ID: 9500549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
    Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosology of Parkinson's disease: looking for the way out of a quagmire.
    Forman MS; Lee VM; Trojanowski JQ
    Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of Parkinson's disease.
    Gasser T
    Adv Neurol; 2001; 86():23-32. PubMed ID: 11553982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
    Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD; Maraganore DM; Silburn PA
    Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease.
    Hatano T; Kubo S; Sato S; Hattori N
    J Neurochem; 2009 Dec; 111(5):1075-93. PubMed ID: 19780902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The gene products for familial Parkinson's disease provide us hints to elucidate the mechanisms of nigral degeneration].
    Hattori N
    Rinsho Shinkeigaku; 2004 Nov; 44(11):821-3. PubMed ID: 15651302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
    Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurogenetics in Parkinson's disease].
    Stefanache F; Hodorog D; Cuciureanu D
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):431-7. PubMed ID: 12092169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-environment interactions in Parkinson's disease and other forms of parkinsonism.
    Vance JM; Ali S; Bradley WG; Singer C; Di Monte DA
    Neurotoxicology; 2010 Sep; 31(5):598-602. PubMed ID: 20430055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of Parkinson's disease.
    Mizuno Y; Hattori N; Mori H
    Biomed Pharmacother; 1999 Apr; 53(3):109-16. PubMed ID: 10349506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of Parkinson disease].
    Brassat D; Durr A; Agid Y; Brice A
    Rev Med Interne; 1999 Aug; 20(8):709-14. PubMed ID: 10480176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.